000			01441nam a2200133Ia 4500
008			220615s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aRecent Advances in Pancreatic Neoplasms
546			_aEnglish[eng]
650			_aPIWI proteins||PIWIL3||PIWIL4||pancreatic cancer||EMT||chemoresistance||motility||HNF4A||survival||pancreatic neuroendocrine neoplasm||primary pancreatic carcinoid||serotonin-secreting pancreatic tumour||serotonin-producing pancreatic tumour||neoadjuvant chemotherapy||response||carbohydrate antigen 19-9||fluorodeoxyglucose||pancreatectomy||positron emission tomography||prognosis||standardized uptake value||Pancreatic ductal adenocarcinoma||microRNAs||pancreatic fistula||pancreatic neoplasm||renal cell carcinoma||pancreatic neoplasms||PET-CT scan||pancreatic ductal adenocarcinoma||pancreatic cancer prognosis||completion total pancreatectomy||pooled analysis||recurrent pancreatic cancer||repeated pancreatectomy||pancreas||neuropathy||taxanes||biomarker||C-reactive protein to albumin ratio||inflammation||intraductal papillary mucinous neoplasm||modified Glasgow prognostic score||neutrophyl lymphocite ratio||platelet-to-lymphocyte ratio||robotic pancreatic surgery||pancreato-gastrostomy||low muscle mass||sarcopenia||pancreatic adenocarcinoma||pancreatic surgery||body composition||n/a
700			_aSperti, Cosimo
856			_uhttps://mdpi.com/books/pdfview/book/5215
942			_cEB
999			_c7809 _d7809